The Meritide program initiated two Phase 3 studies to evaluate longer-term maintenance dosing and switch from weekly GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results